Immunotherapy‐induced reprogramming of cancer‐associated fibroblasts can promote tumor progression
Genes to Cells · 2024
DOI: 10.1111/gtc.13177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, 2024. Verfasst von Tomoya Yamashita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Immunotherapy, Mice, Inbred C57BL. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Takeda Science Foundation, Center for Metabolic Regulation of Healthy Aging (CMHA).
Abstract (Originalsprache)
Use of immune checkpoint inhibitors (ICIs) as cancer immunotherapy has advanced rapidly in the clinic; however, ICI initiation can also cause an unexpectedly rapid acceleration of cancer progression in some patients. Here, we used a murine syngeneic melanoma model to conduct mechanistic analysis of cancer‐associated fibroblast (CAF) function in cancer progression in the context of immunotherapy. We found that after ICI treatment CAFs acquire inflammatory properties, which can promote tumor progression. Mechanistically, we show that T‐cell‐derived interferon‐γ (IFN‐γ) stimulates production of tumor necrosis factor‐α (TNF‐α) by macrophages, facilitating CAF conversion to inflammatory CAFs. Our findings suggest that CAF/immune cell crosstalk plays an essential role in ICI‐associated tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- Pre-Shibasaburo Program, Kumamoto University, Kumamoto, Japan.
- Department of Aging and Geriatric Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- Center for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Molecular and Medical Pharmacology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
ORCID-Profile: Haruki Horiguchi
Förderung
- Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- Takeda Science Foundation
- Center for Metabolic Regulation of Healthy Aging (CMHA)
- Canadian Mental Health Association
Zitieren
APA
Yamashita, T., Horiguchi, H., Kadomatsu, T., Sato, M., Moroishi, T., & Oike, Y. (2024). Immunotherapy‐induced reprogramming of cancer‐associated fibroblasts can promote tumor progression. Genes to Cells. https://doi.org/10.1111/gtc.13177
Vancouver
Yamashita T, Horiguchi H, Kadomatsu T, Sato M, Moroishi T, Oike Y. Immunotherapy‐induced reprogramming of cancer‐associated fibroblasts can promote tumor progression. Genes to Cells. 2024. doi:10.1111/gtc.13177
BibTeX
@article{Yamashita2024,
author = {Yamashita, Tomoya and Horiguchi, Haruki and Kadomatsu, Tsuyoshi and Sato, Michio and Moroishi, Toshiro and Oike, Yuichi},
title = {Immunotherapy‐induced reprogramming of cancer‐associated fibroblasts can promote tumor progression},
journal = {Genes to Cells},
year = {2024},
doi = {10.1111/gtc.13177}
}
EUVIMED